课题基金 / 基金详情

Free Transmission of Human T-cell Leukemia Virus Type 1 to Mouse Cells

Free Transmission of Human T-cell Leukemia Virus Type 1 to Mouse Cells
人类 T 细胞白血病病毒 1 型向小鼠细胞的自由传播
批准号:
10670280
负责人:
MIWA Masanao
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

MIWA Masanao的其他基金

相似基金

相关文献

中文摘要
翻译
人类T细胞白血病病毒1型(HTLV-1)是成人T细胞白血病和HTLV-1相关性脊髓病/热带痉挛截瘫的病原体。然而,只有少数携带者在较长的潜伏期后发展为上述疾病,这给用人类材料研究其发病机制带来了困难。建立HTLV-1相关疾病的小鼠模型有助于了解其发病机制。最近,我们可以通过接种产生HTLV-1的人类细胞来感染新生小鼠。我们发现T细胞、B细胞和粒细胞在体内被感染。但此前已有报道称,无细胞HTLV-1不能有效感染小鼠成纤维细胞。为了了解HTLV-1对小鼠细胞的传播机制,我们利用猫肾细胞系C77产生的一株高传播性的无细胞HTLV-1,并研究了各种小鼠细胞的敏感性。感染9种小鼠细胞系EL4、RLm1、CTLL-2、J774.1、DA-1、BA/F3、WEHI-3、NIH3T3和B1,以及2种人细胞系Molt-4和Hut78,用聚合酶链式反应(PCR)检测HTLV-1前病毒序列。在所有9个小鼠细胞系和2个人细胞系中均发现HTLV-1前病毒序列,并用1名ATL患者的血清阻断感染。此外,无细胞HTLV-1感染小鼠细胞株EL4和RLm1以及人细胞株Molt-4和Hut78的效果相似。这些结果表明HTLV-1有效地无细胞传播到各种小鼠细胞系中,并表明HTLV-1受体在小鼠细胞中广泛分布。
英文摘要
Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent for adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. However, the fact that only a few carriers develop to the above diseases after a long latency makes it difficult to study their pathogenesis with human material. It would be helpful to establish a mouse model of HTLV-1-associated diseases to understand their pathogenesis. Recently we could infect newborn mice by inoculating HTLV-1-producing human cells. We found that T-cells, B-cells and granulocytes were infected in vivo. But it has been previously reported that cell-free HTLV-1 could not infect mouse fibroblast cells efficiently. To understand the mechanism of HTLV-1 transmission to mouse cells, we employed a highly transmissible cell-free HTLV-1 produced by a feline kidney cell line, c77 and studied the susceptibility of various kinds of mouse cells. Nine kinds of mouse cell lines, EL4, RLm1, CTLL-2, J774.1, DA-1, Ba/F3, WEHI-3, NIH3T3 and B1, and two kinds of human cell lines, Molt-4 and Hut78, were infected and the HTLV-1 provirus sequence was monitored by PCR. HTLV-1 proviral sequence was found in all 9 mouse cell lines as well as in 2 human cell lines and infection was blocked with serum from an ATL patient. Moreover mouse cell lines, EL4 and RLm1, and human cell lines, Molt-4 and Hut78, were infected by cell-free HTLV-1 with similar efficiency. These results indicate efficient cell-free HTLV-1 transmission to various mouse cell lines and suggest a wide distribution of HTLV-1 receptor in mouse cells.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Arashi-Hesse N.et al.: "XcmI site-containing vector for direct cloning and in vitro traoscription of PCR product"Molecular Biotechnology. 12. 281-283 (1999)
Arashi-Hesse N.等人:“用于直接克隆和体外转录 PCR 产物的 XcmI 位点载体”分子生物技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Feng,R., et al.: "Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice." Jpn.J.Cancer Res.90. 48-54 (1998)
Feng,R. 等人:“人类 T 细胞白血病病毒 1 型可以感染小鼠体内的多种细胞。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
23
    Identification of acceptor proteins and their modification sites of polyADP-ribosylation and biological function
    Molecular oncological and epidemiological study on initiation and progression of human biliary tract cancer in Asia
    Identification of novel acceptor proteins for polyADP-ribosylation, determination of the site of modification and clarification of biological function
    DETERMINATION OF UNKNOWN POLY(ADP-RIBOSYL)ATED PROTEINS AND BINDING SITES
    国内基金
    海外基金
    HTLV-1病毒通过调控细胞应激颗粒抑制天然免疫并促进病毒复制的机制研究
    • 批准号:
      32370147
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      赵铁军
    • 依托单位:
    PCBP1在HTLV-1感染诱导炎症和致癌过程中的调控作用及其机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      苏芮
    • 依托单位:
    B细胞在HTLV-1相关脊髓病的作用及机制研究
    • 批准号:
      U22A20296
    • 项目类别:
      联合基金项目
    • 资助金额:
      255.00万元
    • 批准年份:
      2022
    • 负责人:
      林毅
    • 依托单位:
    HTLV-1病毒通过HBZ-miR455-AK4/RHOC途径促进白血病发生的分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      54万元
    • 批准年份:
      2022
    • 负责人:
      马广勇
    • 依托单位: